Shorla gains FDA nod for 1st oral version of Novartis` Gleevec
27 Nov 2024 //
BUSINESSWIRE
AZ`s Truqap carves path in prostate cancer with phase 3 win
26 Nov 2024 //
PRESS RELEASE
Siegfried opens global R&D Center for Drug Substance in Switzerland
22 Nov 2024 //
INDPHARMAPOST
Eli Lilly`s weight-loss drug helps nearly 99% of patients remain diabetes-free
14 Nov 2024 //
REUTERS
Patient death prompts Roche to adjust Alzheimer`s trial
31 Oct 2024 //
FIERCE PHARMA
AstraZeneca Pharma India to launch Tremelimumab
23 Sep 2024 //
INDIANPHARMAPOST
MSN`s Generics Clopidogrel Bisulfate Receives Approval in US
20 Sep 2024 //
FDA
Lykos CEO to depart after FDA rejection, layoffs
06 Sep 2024 //
REUTERS
Amgen Plans Phase III Program for Next-Gen Obesity Drug Targeting Liver and Kidney Diseases
06 Sep 2024 //
BIOSPACE
Lilly Gains Ground on Novo With Positive Phase III Readouts for Weekly Insulin
06 Sep 2024 //
BIOSPACE
Travere`s Filspari Gets Full FDA Approval For Kidney Disease
05 Sep 2024 //
FIERCE PHARMA
Ora Partners with Institute of Eye Surgery to Enhance Ophthalmology Access
05 Sep 2024 //
BUSINESSWIRE
Crestone Reports Positive Phase 2 Data for CRS3123 in C. Difficile Infections
05 Sep 2024 //
BUSINESSWIRE
Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial
05 Sep 2024 //
BUSINESSWIRE
Biodesix to Present at Two Investor Conferences in September
05 Sep 2024 //
BUSINESSWIRE
McKesson Sells Rexall and Well.ca to Birch Hill Equity Partners
05 Sep 2024 //
BUSINESSWIRE
KalVista Pharmaceuticals Reports Fiscal Q1 Results and Operational Update
05 Sep 2024 //
BUSINESSWIRE
Orbital Therapeutics Appoints Anna Dixon as Senior Vice President
05 Sep 2024 //
BUSINESSWIRE
WhiteSwell Expands Leadership Team with Key Appointments
05 Sep 2024 //
BUSINESSWIRE
SEQSTER and PatientsLikeMe Partner to Power Connected Health Hub with EHR Data
05 Sep 2024 //
BUSINESSWIRE
Melinta Therapeutics Appoints Sunitha as Chief Technology Officer
05 Sep 2024 //
BUSINESSWIRE
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Sep 2024 //
BUSINESSWIRE
Gilead to Present New Trodelvy® Data at IASLC 2024 World Lung Cancer Conference
05 Sep 2024 //
BUSINESSWIRE
Abdera Therapeutics Receives FDA Orphan Drug Designation for ABD-147
05 Sep 2024 //
BUSINESSWIRE
Vignola is President of Cardiovascular & Metabolic at Worldwide Clinical Trials
05 Sep 2024 //
BUSINESSWIRE
Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery
05 Sep 2024 //
BUSINESSWIRE
Cellares Completes First cGMP Cell Shuttle at IDMO Smart Factory in New Jersey
05 Sep 2024 //
BUSINESSWIRE
OS Therapies to Present at H.C. Wainwright Annual Global Investment Conference
05 Sep 2024 //
BUSINESSWIRE
FDA Supports ?-Synuclein Assay Used in Amprion’s Commercial Test
05 Sep 2024 //
BUSINESSWIRE
CMS Grants Transitional Payment for LUMISIGHT™ and Boosts Breast Cancer Access
05 Sep 2024 //
BUSINESSWIRE
NImmune Biopharma Partners with BioTherapeutics on Inflammation and Immunology
05 Sep 2024 //
BUSINESSWIRE
Iambic Therapeutics Welcomes Dr. Mary Tagliaferri to Board of Directors
05 Sep 2024 //
BUSINESSWIRE
Pfizer Appoints Elif Aral as Regional President for Middle East, Russia & Africa
05 Sep 2024 //
PR NEWSWIRE
Once Weekly Insulin Efsitora Alfa Shows A1C Reduction Similar to Daily Insulin
05 Sep 2024 //
PR NEWSWIRE
Micron Biomedical Expands Advisory Team with Sandeep Patel, PhD
05 Sep 2024 //
PR NEWSWIRE
Rigel Enrolls First Patient in Phase 1b/2 Trial of REZLIDHIA® in mIDH1 AML
05 Sep 2024 //
PR NEWSWIRE
Akebia Therapeutics and U.S. Renal Care Initiate VOICE Trial of Vafseo®
05 Sep 2024 //
PR NEWSWIRE
IntegriChain`s Access Insights Conference to Feature Pharma Thought Leaders
05 Sep 2024 //
PR NEWSWIRE
Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek®
05 Sep 2024 //
PR NEWSWIRE
Hoth Therapeutics Shares Positive Data for EGFRI-Associated Skin Toxicities
05 Sep 2024 //
PR NEWSWIRE
Citius Pharmaceuticals` LYMPHIR™ Added to NCCN Guidelines in Oncology
05 Sep 2024 //
PR NEWSWIRE
Advanced Rx & Sure Med Compliance Join Forces to Reduce Opioid Misuse
05 Sep 2024 //
PR NEWSWIRE
Abbott`s Lingo™ Glucose Monitor Now Available in the U.S.
05 Sep 2024 //
PR NEWSWIRE
Astellas Launches New Life Sciences Center in Cambridge, MA
05 Sep 2024 //
PR NEWSWIRE
Hoth Therapeutics Expands Clinical Sites for HT-001 Phase 2a Trial
05 Sep 2024 //
PR NEWSWIRE
Lykos Therapeutics Appoints Michael Mullette as Interim CEO, Dr. David as CMO
05 Sep 2024 //
PR NEWSWIRE
Citius Pharmaceuticals to Join H.C. Wainwright Global Investment Conference
05 Sep 2024 //
PR NEWSWIRE
Novartis Begins Construction of New Radioligand Therapy Facilities in the US
05 Sep 2024 //
PR NEWSWIRE
Lilly and EVA Pharma Collaborate to Expand Baricitinib Access in Africa
05 Sep 2024 //
PR NEWSWIRE